|
|
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (May 2010) |
ARYx Therapeutics, Inc. (NASDAQ: ARYX) is an American biopharmaceutical company, headquartered in Fremont, California, focused on developing a portfolio of internally discovered product candidates.
The company uses its RetroMetabolic Drug Design technology to design molecules that retain the efficacy of original and well-established drugs but which are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these original compounds.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)